Van Andel Institute, a research and educational company, engages in biomedical research with a focus on genetic, cellular, and molecular origins of cancer and Parkinson disease. It provides services, including antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation, and Michigan animal consortium, as well as analytical, cellular, and molecular microscopy services. The company also offers studies on osteoporosis and diabetes. In addition, it provides science education through scie...
333 Bostwick Avenue N.E.
Grand Rapids, MI 49503
Founded in 1996
Van Andel Institute Appoints Mark Meijer to its Board of Trustees
Apr 30 14
Van Andel Institute appointed Mark Meijer to its board of trustees on April 21, 2014. Meijer founded Life E.M.S. Ambulance in 1980 with one used vehicle licensed for service. A frequent speaker on the topic of emergency medical services, Meijer has been appointed to several key leadership roles in the industry. He continues to maintain his licensure as a paramedic in Michigan. With extensive background and employment history in the retail industry, Meijer also serves on the board of Meijer Inc.
Van Andel Institute Establishes Global Epigenetics Research Hub
Feb 28 14
Van Andel Institute has established a global epigenetics research hub, tapping into a research topic responsible for new and innovative approaches to personalized cancer therapy. Epigenetics is widely regarded as the most significant new area of cancer research; it is the study of heritable changes in gene activity which are not caused by changes in the DNA sequence.